Tag Archives: Business Insider

Gilead makes breakout M&A move; buys CAR-T wunderkind Kite Pharma for $12 billion.

The News: Gilead Sciences Inc. (Foster City CA) announced it would buy cancer-immune therapy company Kite Pharma Inc. (Santa Monica CA) for about $11.9 billion to bolster its hugely successful but… Read more »

Trump’s Exec Order on drug pricing proves he’s like the leopard; he can’t change his spots

A draft of President Donald Trump’s executive order on drug prices lists several proposals to lessen regulatory hurdles for the pharmaceutical industry, reports The New York Times. Here are four things… Read more »

UnitedHealth crushes 1Q estimates post Obamacare dump; first to jettison social conscience now taking leadership role

The News: UnitedHealth Group Inc. (Minnetonka MN) posted stronger-than-expected earnings Tuesday (April 18, 2017) in the first quarter without the vast majority of its Affordable Care Act-compatible individual health-insurance business. The… Read more »

Valeant CEO tries to paint happy face on 4Q results; markets not buying the turnaround–yet?

The News: Valeant Pharmaceuticals International Inc.’s (Laval Quebec) fourth-quarter loss widened to $515 million versus $385 million in the same period of 2015, as sales plummeted 13% year-over-year to $2.4… Read more »

Trumpcare slowly imploding; perhaps morphing into Obamacare 2.0?

Steve’s Take: Six years after its passage, the Affordable Care Act has demonstrated it’s far from perfect. But replacing such an immense, complicated law on an accelerated schedule is presenting… Read more »

Mallinckrodt will pay $100 million to settle drug antitrust (price-gouging) charges; why competition, not fines, is the only antidote

The News: Irish drugmaker Mallinckrodt PLC (Dublin) and a US subsidiary will pay $100 million and agree to other conditions to settle government antitrust allegations they unlawfully prevented competition for… Read more »

Novo Nordisk to cap price increases as drug costs face more scrutiny; do two drugmakers equal a trend?

With drug companies under fire over prices, the world’s largest insulin maker plans to limit increases and join competitors by introducing a model that ties the cost of medicines to… Read more »

Texas reports first Zika case from local mosquito; virus is now here to stay, says WHO

Texas health officials on Monday (December 28,2016) reported the state’s first case of Zika likely spread by local mosquitoes, making Texas the second state within the continental United States to… Read more »

Former Valeant and Philidor executives charged in kickback scheme; how management got fooled, or so they say

Federal prosecutors filed charges against former Valeant Pharmaceuticals International Inc. (Laval Québec) executive Gary Tanner and former Philidor Rx Services LLC (Hatboro PA) CEO Andrew Davenport, alleging they engaged in… Read more »